Literature DB >> 2036480

Caffeine-induced anxiety and increase of kynurenine concentration in plasma of healthy subjects: a pilot study.

A Orlikov1, I Ryzov.   

Abstract

The concentration of kynurenine, a neuroactive tryptophan metabolite, in blood plasma after pharmacologically induced anxiety was studied. Anxiety was provoked in 15 healthy volunteers by an anxiogenic dose of caffeine. Kynurenine concentration was markedly increased at the peak of anxiety and returned to normal after anxiety had abated. Possible causes responsible for this effect are discussed. There is a correlation between kynurenine concentration in blood plasma and indices of state and trait anxiety (Spielberger-Khanin scale) and anxiety (Hamilton scale) at baseline. The correlation disappears at the peak of anxiety. It is suggested that kynurenine is involved in caffeine-induced anxiety in humans. The absence of correlation at the peak of caffeine-induced anxiety is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036480     DOI: 10.1016/0006-3223(91)90225-b

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  3 in total

Review 1.  IDO/kynurenine pathway in cancer: possible therapeutic approaches.

Authors:  Eslam E Abd El-Fattah
Journal:  J Transl Med       Date:  2022-08-02       Impact factor: 8.440

Review 2.  Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression.

Authors:  Giampaolo Perna; Giuseppe Iannone; Alessandra Alciati; Daniela Caldirola
Journal:  Neural Plast       Date:  2015-12-31       Impact factor: 3.599

Review 3.  Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders.

Authors:  Yong-Ku Kim; Sang Won Jeon
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.